ABOUT / MY PERSPECTIVE
I came into commercial transformation through the work itself.
I began in healthcare marketing and communications consulting, where I learned to translate a client's commercial problem into a brief, a team, a delivery plan and a result. Later, at Abbott, I moved through digital product, multichannel marketing and regional digital leadership roles. That progression matters: I have worked both on the details of execution and on the operating choices that allow teams across markets to deliver.
My experience spans the Middle East, Africa, Turkey and Pakistan, working with brands, agencies, field teams and cross-functional stakeholders. Earlier roles included designing customer journeys, running multichannel programs and establishing measurement processes. Those experiences are why I pay attention to the point where a good strategy meets the practical constraints of a market.
The questions I keep asking are concrete. Does the field team know what happened in the digital channel? Can a commercial review change a resource decision? Did the new system remove work, or simply add another layer? Is a local team being consulted early enough to influence the design? These questions connect commercial performance, customer experience and transformation far more usefully than a list of technologies.
HOW I THINK ABOUT LEADERSHIP
I have learned to value the questions that make a decision harder—and better.
In a regional organization, different functions often see different parts of the same problem. Medical, commercial, digital, finance and country teams will not always agree. I think leadership means making the trade-offs explicit, distinguishing a material risk from a preference and being clear about who makes the decision. That does not mean rushing choices involving patient safety, privacy or compliance.
I am interested in the mechanics of execution: how teams coordinate HCP engagement, how evidence informs commercial priorities, how global programs adapt to local realities and how technology changes daily work. AI is part of that conversation, but it is not the starting point. The business problem is.
BACKGROUND
Commercial foundations. Enterprise scope.
My professional background includes healthcare consulting roles at InterMark and IMN Health Network, followed by digital product, multichannel and regional digital marketing roles at Abbott. My 2020 CV documents work across multiple countries and therapy areas, customer journeys, campaigns and cross-functional programs. I hold a pharmacy degree from Ain Shams University, an MBA from the German University in Cairo and an Executive MBA from London Business School. I have subsequently worked on global marketing and enterprise transformation initiatives. I do not publish employer-specific performance claims here.
This website shares independent perspectives and practical decision tools. Examples illustrate common business situations; they are not representations of confidential employer projects or unpublished results.
Explore Articles & Ideas ↗Three questions. One operating challenge.
These are the recurring questions that connect my professional experience to the work published here.
1. Who has the authority to decide?
Clarify accountability, decision rights and when a human must be able to challenge a system or a standard.
Explore AI accountability →Explore global–local decision rights →2. What evidence would change the decision?
Separate persuasive dashboards and demonstrations from proof that an investment or review changes outcomes.
Explore the AI investment decision →Explore commercial reviews that end in decisions →3. What changes in the actual workflow?
Look beyond launch, activity and channel metrics: identify what work disappears, what handoff improves and who owns the result.
Explore transformation after go-live →Explore omnichannel handoffs →EXPLORE THE THINKING
From a point of view to a decision.
I write about the decisions that sit between functions, markets and technologies. The accompanying tools are designed to help teams make those decisions explicit.
EVIDENCE, ATTRIBUTION & INDEPENDENT SOURCES
An original executive perspective, grounded in published standards.
Ghada Elkhodiry writes about the gap between commercial strategy and decisions that actually change work. Her Authority × Evidence × Workflow lens is her editorial synthesis—not a framework endorsed by the institutions below. These primary sources provide context for the governance and accountability arguments.
Author: Ghada Elkhodiry · Executive perspectives on pharmaceutical commercial leadership, customer engagement, organizational transformation and accountable AI. Professional profile: LinkedIn ↗
Original frameworks and practical decision tools
I publish under Ghada Elkhodiry (also written Ghada El Khodiry). My work connects accountable AI decisions, decision latency and the cost of local exceptions. These are practitioner frameworks for testing leadership choices—not regulatory standards or employer-endorsed methods.
Human Override Test — when a reviewer can actually say noDecision Latency Tax — the wait between evidence and authorityException Budget — govern local deviations as obligationsThe views I share are my own and do not represent those of my employer.